MILTON MEDICAL CENTRE is an innovative Canadian pharma-technology company that brings drug delivery solutions to a new level. The Company conducts pharmaceutical Research & Development for medical innovations, production, and consultations to the pharmaceutical and healthcare manufacturing industry.
As a Canadian life sciences company we are proud to provide disruptive proprietary drug delivery technologies designed to improve patient outcomes.
PRODUCTS: Vitamins B6 and B12 + Sleep and Energy Boost Supplements in the form of strips.
QuickStrip is the final form that will be taken by the consumer or patient. By placing the strip under the tongue, inside the cheek, or directly on the tongue and allowing it to dissolve for a few seconds, the active molecule is released from the strip and rapidly delivered across the tissue into the blood stream.
BENEFITS:
Rapid Delivery QuickStrip is designed to provide rapid delivery for faster clinical effect and symptom relief. A recognized solution for patients that cannot swallow pills or who require immediate drug delivery, QuickStrip delivers drugs to the blood stream through the oral mucosa to mitigate side effects by lowering the dose or changing the route of delivery. A proven drug delivery system that can replace the use of injectable drugs while still providing precision dosing for drugs that need careful titration. Companies can combine multiple actives in one dose for combination products and create variable rapid dosing solutions based on the needs of the patient. Easy to use, store, and transport with a long shelf life due to the child resistant environmental barrier packaging, QuickStrip offers consumers and patients an alternative method to take their medication.
Elderly Patients QuickStrip simplifies drug delivery process for patients with minor to severe challenges with swallowing. Given the number of drugs the elderly are prescribed, the QuickStrip system can decrease the burden associated with treatment. Elderly patients are inherently predisposed to dysphagia predominately because of comorbid health conditions.With the aging of the population globally, along with the increased prevalence of obesity and gastroesophageal reflux disease, healthcare providers will increasingly encounter older patients with either oropharyngeal or esophageal disease and complaints of dysphagia.
Pediatrics QuickStrip system delivers a quantity of drug directly to the blood stream instead of only through the gastrointestinal tract. Although clinical dysphagia may not be present even small pills may not be well received by young patients or may be contraindicated due to the risk of choking. Liquid delivery options do exist, but in the pediatric patient is prone to vomiting. Nausea and vomiting are common in children, and are usually part of a mild, short-lived illness, frequently caused by a viral infection. It can be hard to tell if an infant is spitting up or vomiting because some infants reflux forcefully or in large amounts. When delivering therapeutic doses of a drug to a young patient, it is important to know how much they are getting and how much they are retaining. QuickStrip delivers medication to children in a safe and easy to use format for both the young patient and the caregiver.
Neuro Dysphagia and other challenges with swallowing are a constant concern in neurological conditions. Innovative delivery systems like QuickStrip offer patients a tremendous benefit for delivering critical medication without the need for pills or injections. Soluble APIs that could benefit from a direct delivery channel that bypasses first pass metabolism are excellent candidates for the rapid delivery systems. Clinical studies have clearly indicated that QuickStrip is an alternative to injections or intravenous delivery. Lower doses, faster delivery, and reliable pharmacokinetics are the key goals for such delivery systems.